Evidence map›Paper›PMID 32975237›Full record

ReviewJournal of biosciences2020

Ankita Saxena, Asish Kumar Mukhopadhyay, Shoma Paul Nandi

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Novel anti-virulence strategy againstFrontiers in microbiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Antibiotics (Basel, Switzerland) · 2023
    Review
  9. Review
  10. Association between dietary zinc intake andFrontiers in nutrition · 2023
    Article
  11. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ankita SaxenaAmity Institute of Biotechnology, Amity University, Noida, India.
Asish Kumar Mukhopadhyay
Shoma Paul Nandi
Amity University · INNational Institute of Cholera and Enteric Diseases · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternate remedies with natural products provides unlimited opportunities for new drug development. These can be either as pure compounds or as standardized set of compounds. The phytochemicals and secondary metabolites are in great demand for screening bioactive compounds and plays an important role towards drug development. Natural products have many advantages over to synthetic chemical drugs.

Indexed as

AmoxicillinAnti-Bacterial AgentsBiological ProductsBismuthClarithromycinDrug Therapy, CombinationDysbiosisGastrointestinal MicrobiomeHelicobacter InfectionsHelicobacter pyloriHumansLansoprazolePhytochemicalsPlant ExtractsPlants, MedicinalProbioticsAmoxicillinAnti-Bacterial AgentsBiological ProductsBismuthClarithromycinLansoprazolePhytochemicalsPlant Extracts

Identifiers

PMID32975237
PMCPMC7481552
OpenAlexW3084239115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.